2FX as an alternative for traditional antibitoics
Mastitis remains one of the most prevalent and costly diseases in dairy farming, leading to significant reductions in milk yield, increased veterinary costs, and premature culling of animals. Conventional treatment relies heavily on antibiotics, which, while effective, contribute to antimicrobial resistance and result in milk withdrawal periods that negatively impact farm economics.
The integration of 2FX into standard intramammary injectors provides a novel, non-antibiotic approach to mastitis management. Upon application, 2FX selectively neutralizes the harmful microbes at subclinical mastitis and forms a protective biofilm along the udder epithelium. The mechanism effectively neutralizes harmful microbes before infection is established.
The clinical relevance of this approach is considerable:
-
Infection prevention: pathogens are neutralized at the site of entry, reducing the risk of acute and subclinical mastitis.
-
Inflammation control: by limiting bacterial adhesion, inflammatory responses are mitigated, preserving tissue integrity.
-
Reduced antibiotic dependency: 2FX provides a natural alternative to antibiotics that supports udder health while addressing global concerns regarding antimicrobial resistance.
-
Sustained productivity: Because 2FX is food grade, cows remain in lactation, reducing economic losses and ensuring a consistent milk supply.
Evidence from clinical evaluation, including trials conducted in collaboration with Dairy Campus, supports the efficacy of this method. By introducing 2FX into mastitis treatment, dairy farmers gain access to a sustainable solution that benefits animal welfare, farm economics, and consumer safety alike.
